Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001274737-24-000074
Filing Date
2024-08-02
Accepted
2024-08-02 17:20:36
Documents
13
Period of Report
2024-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A exdx-20240731.htm   iXBRL 8-K/A 39124
  Complete submission text file 0001274737-24-000074.txt   169068

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20240731.xsd EX-101.SCH 1898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20240731_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20240731_pre.xml EX-101.PRE 13041
15 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20240731_htm.xml XML 2796
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39049 | Film No.: 241172248
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)